Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines

Cell Growth and Differentiation

Volumn 7, Issue 6, 1996, Pages 787-796

  Melino, Gerry ^a,c   Draoui, Muriel ^d   Bernardini, Sergio ^b   Bellincampi, Lorenza ^a,c   Reichert, Uwe ^e   Cohen, Paul ^d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d SORBONNE UNIVERSITÉ   (France)

^e Galderma R and D   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULINASE; METALLOPROTEINASE; PROTEINASE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; SOMATOMEDIN B;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INSULIN DEGRADATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PROCESSING;

ENDOPEPTIDASES; HUMANS; INSULYSIN; MOLECULAR STRUCTURE; NEUROBLASTOMA; NEUROECTODERMAL TUMOR, MELANOTIC; THERMOLYSIN; TRETINOIN; TUMOR CELLS, CULTURED;

LEUCISCUS IDUS;

EID: 0029827326     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Han, V. K. M., D'Ercole, A. J., and Lund, P. K. Cellular localization of somatomedin messenger RNA in the human fetus. Science (Washington DC), 236: 193-196, 1987.
2. Brice, A. L., Cheetham, J. E., Bolton, V. N., Hill, N. C., and Schofield, D. Temporal changes in the expression of insulin-like growth factor II gene associated with tissue maturation in the fetus. Development, 106: 543-549, 1989.
3. Humbel, R. E. Insulin-like growth factors I and II. Eur. J. Biochem., 190: 445-462, 1990.
4. EI-Badry, O., Helman, L. J., Chatten, J., Steinberg, S. M., Evans, A. E., and Israel, M. A. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J. Clin. Invest., 87: 648-657, 1991.
5. El-Badry, O., Romanus, J. A., Helman, L. J., Cooper, M. J., Rechler, M., and Israel, M. A. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J. Clin. Invest., 84: 829-839, 1989.
6. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
7. Voutilaine, R., and Miller, W. L. Coordinate tropic hormone regulation of mRNAs for insulin growth factor II and the cholesterol side-chain-cleavage enzyme, p450ssc, in human steroidogenic tissues. Proc. Natl. Acad. Sci. USA, 84: 1590-1594, 1987.
8. Depagter-Holthuizen, P., Jansen, M., Van Schaik, F. M. A., Van der Kammen, R., Oosterwijk, C., Van der Brande, J. L., and Sussenback, J. S. The human insulin-like growth factor-II gene contains two development-specific promoters. FEBS Lett., 214: 259-264, 1987.
9. Gray, A., Tarn, A. W., Dull, T. J., Hayflick, J., Pintar, J., Cavenee, W. K., Koufos, A., and Ullrich, A. Tissue-specific and developmentally regulated transcription of the insulin-like growth factor 2 gene. DNA, 6: 283-295, 1987.
10. de Moor, C. H., Jansen, M., Sussenbach, J. S., and van den Brande, J. L. Differential polysomal localization of human insulin-like growth factor II mRNAs in cell lines and foetal liver. Eur. J. Biochem., 222: 1017-1024, 1994.
11. Shimasaki, S., and Ling, N. Identification and molecular characterization of insulin-like growth factor binding protein (IGFBP1-6). Prog. Growth Factor Res., 3: 243-266, 1991.
12. Andress, D. L., and Birnbaum, R. S. Human osteoblast-derived IGFBP-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem., 267: 22467-22472, 1992.
13. Steele-Perkins, G., Turner, J., Edman, J. C., Hari, J., Pierce, S. B., Stover, C., Rutter, W. J., and Roth, R. A. Expression and characterization of a functional human insulin-like growth factor I receptor. J. Biol. Chem., 263: 11486-11492, 1988.
14. McDonald, R. G., Pfeffer, S. R., Coussens, L., Tepper, M. A., Brokeland, C. M., Mole, J. E., Anderson, J. K., Chen, E., Czech, M. P., and Ullrich, A. A single receptor binds both insulin-like growth factor II and mannose 6-phosphate. Science (Washington DC), 239: 1134-1137, 1988.
15. Rechler, M. M., Zapf, J., Nissley, S. P., Froesh, E. R., Moses, A. C., Podskalny, J. M., Schilling, E. E., and Humbel, R. E. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology, 107: 1451-1459, 1980.
16. Roth, R. A., Mesirow, M. L., Yokono, K., and Saba, S. Degradation of insulin growth factors I and II by a human insulin degrading enzyme. Endocr. Res., 10: 101-112, 1984.
17. Duckworth, W. C. Insulin metabolism and degradation. Endocr. Rev., 9: 319-345, 1988.
18. Authier, F., Rachubinski, R. A., Posner, B. I., and Bergeron, J. J. M. Endosomal proteolysis of insulin by an acid thiol metalloprotease unrelated to insulin degrading enzyme. J. Biol. Chem., 269: 3010-3016, 1994.
19. Affholter, J. A., Hsieh, C., Francke, U., and Roth, R. A. Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes. Mol. Endocrinol., 4: 1125-1135, 1990.
20. Bondy, C. A., Zhou, J., Chin E., Reinhardt, R. R., Ding, L., and Roth, R. A. Cellular distribution of insulin-degrading enzyme gene expression. J. Clin. Invest., 93: 966-973, 1994.
21. Bernardini, S., Cianfarani, S., Spagnoli, A., Annicchiarico-Petruzzelli, M., Melino, G., Massoud, R., Boscherini, B., Finazzi-Agrô, A., Rosenfeld, R. G., and Federici, G. J. Expression and down regulation by retinoic acid of IGF binding protein -2 and -5 in medium from human neuroblastoma cells. Neuroendocrinology, 6: 409-413, 1994.
22. Ciccarone, V., Spengler, B. A., Meyers, M. B., Biedler, J. L., and Ross, R. A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res., 49: 219-225, 1989.
23. Melino, G., Annicchiarico-Petruzzelli, M., Piredda, L., Candi, E., Gentile, V., Davies, P. A. J., and Piacentini, M. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell Biol., 14: 6584-6596, 1994.
24. Melino, G., Stephanou, A., Annicchiarico-Petruzzelli, M., Knight, R. A., Finazzi-Agró, A., and Lightman, S. L. Modulation of IGF-II expression during growth and differentiation of human neuroblastoma cells: retinoic acid may induce IGF-II. Neurosci. Lett., 151: 187-191, 1993.
25. Matsumoto, K., Gaetano, C., Daughday, W. H., and Thiele, C. Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line. J. Endocrinol., 130: 3669-3676, 1992.
26. Matsumoto, K., Lucarelli, E., Minniti, C., Gaetano, C., and Thiele, C. Signals transduced via IGF-R mediate resistance to retinoic acid-induced cell growth arrest in a human neuroblastoma cell line. Cell Death Differ., 1: 67-76, 1994.
27. Carvalho, K. M., Joudiou, C., Boussetta, H., Leseney, A. M., and Cohen, P. A peptide-hormone-inactivating endopeptidase in Xenopus laevis skin secretion. Proc. Natl. Acad. Sci. USA, 89: 84-88, 1992.
28. Joudiou, C., De Morais Carvalho, K., Camarao, G., Boussetta, H., and Cohen, P. Characterization of the thermolysin-like cleavage of biologically active peptides by Xenopus laevis peptide hormone inactivating enzyme. Biochemistry, 32: 5959-5966, 1993.
29. Carvalho, K. D., DeLaurenzi, V., Melino, G., and Cohen, P. Modulation of activity of a novel thermolysin-like metallo-endopeptidase during retinoic acid-induced differentiation of human neuroectodermal tumour cell lines. Biochem. Biophys. Res. Commun., 191: 172-179, 1993.
30. Thiele, C. J., Reynolds, C. P., and Israel, M. A. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines. Oncogene, 3: 281-288, 1985.
31. Piacentini, M., Annicchiarico-Petruzzelli, M., Oliverio, S., Piredda, L., Biedler, J. L., and Melino, G. Phenotype-specific tissue-transglutaminase regulation in human neuroblastoma cells is response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer, 52: 271-278, 1992.
32. Tajena, R., Bouillet, P., Boylan, J. F., Gaub, M., Bibyut, R., Gudas, L., and Chambon, P. Reexpression of retinoic acid receptor (RAR)γ or overexpression of RARα or RARβ in RARγ-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc. Natl. Acad. Sci. USA, 92: 7854-7895, 1995.
33. Saitou, S., Tanaka, T., Shimouchi, K., Fuchs, E., Narumiya, S., and Kakizuka, A. Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature (Lond.), 374: 159-162, 1995.
34. Bennett, M. R., Evan, G. I., and Schwartz, S. M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest., 95: 2266-2274, 1995.
35. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor present etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
36. Wu, X., Fan, Z., Masui, H., Rosen, N., and Mendelsohn, J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. Clin. Invest, 95: 1897-1905, 1995.
37. Chun, S. Y., Billig, H., Tilly, J. L., Furuta, I., Tsafriri, A., and Hsueh, A. J. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I. Endocrinology, 135: 1845-1853, 1994.
38. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
39. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
40. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16: 3-34, 1995.
41. Redfern, C. P. F., Lovat, P. E., Malchom, A. J., and Pearson, A. D. J. Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid. Eur. J. Cancer, 31A: 486-494, 1995.
42. Li, C., Einhorn, P. A., and Reynolds, C. P. Expression of retinoic acid receptors α, β, γ in human neuroblastoma cell lines. Adv. Neuroblastoma Res., 4: 221-227, 1994.
43. Han, G., Chang, B., Connor, M. J., and Sidell, N. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells. Differentiation, 59: 61-64, 1995.
44. Berard, J., Gaboury, L., Landers, M., De Repentigny, Y., Houle, B., Kothary, R., and Bradley, C. Hyperplasia and tumours in lung, breast, and other tissues in mice carrying a RARβ4-like transgene. EMBO J., 13: 5570-5580, 1994.
45. Chen, D., and Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (Lond.), 377: 454-457, 1995.
46. Hörlein, A. J., Näär, A. M., Heizel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, R., Karnei, Y., Söderström, M., Glass, C. K., and Rosenfeld, M. G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear co-repressor. Nature (Lond.), 377: 397-404, 1995.
47. Kurokawa, R., Söderström, M., Hörlein, A. J., Halachmi, S., Brown, M., Glass, C. K., and Rosenfeld, M. G. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (Lond.), 377: 451-454, 1995.
48. Shah, N., Zhang, S., Harada, S., Smith, R. M., and Jarett, L. Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells during covalently linked Nanogold-insulin. Endocrinology, 136: 2825-2835, 1995.
49. Harada, S., Smith, R. M., Smith, J. A., Shah, N., and Jarett, L. Demonstration of specific insulin binding to cytosolic protein in H35 hepatoma cells, rat liver and skeletal muscle. Biochem. J., 306: 21-28, 1995.
50. Savarese, A., Annicchiarico-Petruzzelli, M., Citro, M., Zupi, G., Spagnoli, L. G., Colantoni, A., Vernole, P., Stephanou, A., Knight, R. A., Guerrieri, P., and Melino, G. Characterisation of a novel human glioblastoma cell line (LI) expressing hypothalamic and pituitary hormones. Exp. Brain Res., 89: 408-414, 1992.
51. Wu, T. J., Wang, L., and Wan, Y. J. Retinoic acid regulates gene expression of retinoic acid receptors α, β and γ in F9 mouse teratocarcinoma cells. Differentiation, 51: 219-224, 1992.
52. 124 bond. Biochem. Biophys. Res. Commun., 182: 158-164, 1992.
53. Kuo, W., Ghern, B. D., Rosner, M., Li, W., and Keller, G. Inducible expression and cellular localization of Insulin-degrading enzyme in a stably transfected cell line. J. Biol. Chem., 269: 22599-22606, 1994.